BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23440423)

  • 21. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
    Yu T; Chen X; Zhang W; Liu J; Avdiushko R; Napier DL; Liu AX; Neltner JM; Wang C; Cohen D; Liu C
    Cell Death Differ; 2016 Feb; 23(2):207-15. PubMed ID: 26113043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl.
    Nwaeburu CC; Bauer N; Zhao Z; Abukiwan A; Gladkich J; Benner A; Herr I
    Oncotarget; 2016 Sep; 7(36):58367-58380. PubMed ID: 27521217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells.
    D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB
    BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
    Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
    Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
    J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells.
    Wang J; Wang B; Chen LQ; Yang J; Gong ZQ; Zhao XL; Zhang CQ; Du KL
    Biomed Pharmacother; 2016 Dec; 84():947-953. PubMed ID: 27764757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4.
    Ma J; Yao Y; Wang P; Liu Y; Zhao L; Li Z; Li Z; Xue Y
    Cancer Lett; 2014 Dec; 355(1):85-95. PubMed ID: 25218589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
    Yu F; Li J; Chen H; Fu J; Ray S; Huang S; Zheng H; Ai W
    Oncogene; 2011 May; 30(18):2161-72. PubMed ID: 21242971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.
    Chiu KL; Lin YS; Kuo TT; Lo CC; Huang YK; Chang HF; Chuang EY; Lin CC; Cheng WC; Liu YN; Lai LC; Sher YP
    Oncotarget; 2017 Jul; 8(29):47365-47378. PubMed ID: 28537886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-570 promotes lung carcinoma proliferation through targeting tumor suppressor KLF9.
    Tong XD; Liu TQ; Wang GB; Zhang CL; Liu HX
    Int J Clin Exp Pathol; 2015; 8(3):2829-34. PubMed ID: 26045791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2.
    Zhang JX; Chen ZH; Xu Y; Chen JW; Weng HW; Yun M; Zheng ZS; Chen C; Wu BL; Li EM; Fu JH; Ye S; Xie D
    Clin Cancer Res; 2017 Jan; 23(1):298-310. PubMed ID: 27407092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
    Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
    Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.
    Kong F; Sun T; Kong X; Xie D; Li Z; Xie K
    Clin Cancer Res; 2018 May; 24(10):2440-2451. PubMed ID: 29367428
    [No Abstract]   [Full Text] [Related]  

  • 37. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
    Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
    Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma.
    Hu W; Hofstetter WL; Li H; Zhou Y; He Y; Pataer A; Wang L; Xie K; Swisher SG; Fang B
    Clin Cancer Res; 2009 Sep; 15(18):5688-95. PubMed ID: 19737957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.
    Zhou Y; Hofstetter WL; He Y; Hu W; Pataer A; Wang L; Wang J; Zhou Y; Yu L; Fang B; Swisher SG
    Cancer Biol Ther; 2010 Apr; 9(7):507-13. PubMed ID: 20215880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.